[ Skip to the content ]

Institute of Formal and Applied Linguistics Wiki

[ Back to the navigation ]

You are here: start » projects » content-annotation » guess » article-1

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision 		Previous revision
projects:content-annotation:guess:article-1 [2007/05/29 10:12]
novak 		projects:content-annotation:guess:article-1 [2007/05/29 10:56] (current)
novak
Line 11: Line 11:
  
 **CW:** Australian pharmaceutical company, F.H. Faulding & Company, said its affiliate, Moleculon Inc. has acquired Kalipharma Inc. for $23 million.  Kalipharma, a New Jersey-based pharmaceutical concern, sells its various products under the Purepac label.  Faulding said it owns 33% of Moleculon's voting stock and has the agreement to acquire an additional 19%.  That stake, associated with convertible, preferred stock holdings, gives Faulding the right to increase its interest in Moleculon's voting stock to 70%. **CW:** Australian pharmaceutical company, F.H. Faulding & Company, said its affiliate, Moleculon Inc. has acquired Kalipharma Inc. for $23 million.  Kalipharma, a New Jersey-based pharmaceutical concern, sells its various products under the Purepac label.  Faulding said it owns 33% of Moleculon's voting stock and has the agreement to acquire an additional 19%.  That stake, associated with convertible, preferred stock holdings, gives Faulding the right to increase its interest in Moleculon's voting stock to 70%.
 +
  
 ===== Original Article ===== ===== Original Article =====
  
-F.H. Faulding & Co., an Australian pharmaceuticals company, said its Moleculon Inc. affiliate acquired Kalipharma Inc. for $ 23 million. Kalipharma is a New Jersey-based pharmaceuticals concern that sells products under the Purepac label. Faulding said it owns 33 % of Moleculon's voting stock and has an agreement to acquire an additional 19%. That stake, together with its convertible preferred stock holdings, gives Faulding the right to increase its interest to 70% of Moleculon's voting stock.+F.H. Faulding & Co., an Australian pharmaceuticals company, said its Moleculon Inc. affiliate acquired Kalipharma Inc. for $ 23 million. Kalipharma is a New Jersey-based pharmaceuticals concern that sells products under the Purepac label. Faulding said it owns 33% of Moleculon's voting stock and has an agreement to acquire an additional 19%. That stake, together with its convertible preferred stock holdings, gives Faulding the right to increase its interest to 70% of Moleculon's voting stock.
MultiNet (Multilayered Extended Semantic Networks) is developed and maintained
by Intelligent Information and Communication Systems Department of FernUniversität in Hagen.

[ Back to the navigation ] [ Back to the content ]